Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study

By sjmartinez • December 21, 2022

Kudo M, Finn RS, Qin S, Han KH, Ikeda K, Cheng AL, Vogel A, Tovoli F, Ueshima K, Aikata H, López CL, Pracht M, Meng Z, Daniele B, Park JW, Palmer D, Tamai T, Saito K, Dutcus CE, Lencioni R. Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study. J Hepatol. 2023 Jan;78(1):133-141. doi: 10.1016/j.jhep.2022.09.006. Epub 2022 Sep 20. PMID: 36341767.

Tags: Digestive Diseases, landmark analysis, lenvatinib, mRECIST, Publications, response status, surrogate endpoint

Sex Disparities in Alcohol-Associated Liver Disease and Subtype Differences in Alcohol-attributable Cancers in the United States

Danpanichkul P, Pang Y, Mahendru T, Tothanarungroj P, Díaz LA, Arab JP, Jatupornpakdee P, Muthiah MD, Duangsonk K, Choi WM, Huang DQ, Kim D, Noureddin[...]

Clinical and HLA associations of fluoroquinolone induced liver injury: results from the Drug-Induced Liver Injury Network

Ahmad J, Dellinger A, Nicoletti P, Barnhart HX, Ghabril M, Fontana RJ, Navarro V, Choi G, Hayashi PH, Gu J, Kleiner D; Drug-Induced Liver Injury[...]

Deep Learning Methods in the Imaging of Hepatic and Pancreaticobiliary Diseases

Ramai D, Collins B, Ofosu A, Mohan BP, Jagannath S, Tabibian JH, Girotra M, Barakat MT. Deep Learning Methods in the Imaging of Hepatic and[...]